YTHDF2 is a potential target of AML1/ETO-HIF1α loop-mediated cell proliferation in t(8;21) AML

Area of Science:

• Molecular Biology
• Cancer Research
• Hematology

Background:

• The t(8;21) fusion product AML1/ETO and hypoxia-inducible factor 1α (HIF1α) form a transcription loop impacting DNA methylation and leukemia growth.
• YTHDF2, an RNA m6A reader, plays a specific role in acute myeloid leukemia (AML) stem cells.

Purpose of the Study:

• To investigate the relationship between the AML1/ETO-HIF1α loop and YTHDF2 in t(8;21) AML.
• To elucidate the functional role of YTHDF2 in t(8;21) AML pathogenesis.

Main Methods:

• Analysis of YTHDF2 expression in t(8;21) AML patients.
• In vitro and in vivo knockdown of YTHDF2 in leukemia cells.
• Investigation of HIF1α binding to the YTHDF2 promoter.
• Assessment of global mRNA m6A levels and TNFRSF1b expression following YTHDF2 manipulation.

Main Results:

• YTHDF2 is highly expressed in t(8;21) AML and linked to poor prognosis.
• YTHDF2 knockdown inhibits leukemia cell proliferation in vitro and in vivo.
• HIF1α directly upregulates YTHDF2 expression in t(8;21) AML cells.
• YTHDF2 knockdown increases global mRNA m6A levels and TNFRSF1b expression.

Conclusions:

• YTHDF2 is a downstream target of the AML1/ETO-HIF1α loop in t(8;21) AML.
• YTHDF2 promotes leukemia cell proliferation, potentially via modulation of global m6A methylation.
• YTHDF2 represents a potential therapeutic target for t(8;21) AML.